Implementing a Clinical Data Repository and Analytics Platform in 90 Days

April 18, 2017

There is no doubt that the effort and cost to bring a drug successfully to market is significant. In addition, once approved, pharmaceutical and biotechnology companies face intense competitive pressures including crowded marketplaces of newly approved drugs. In the years from 2005-2011, the median time from the first and second entrant in a newly approved drug class was 2.3 years compared with 4.7 years from 1998-2004. 

Spotlight

Quintica

Streamlining and automating business processes and workflows, capturing and analyzing key customer data from internal and external sources and the proactive monitoring of infrastructure and support applications with real time visibility all in one location is at the heart of delivering better customer experiences.

OTHER WHITEPAPERS
news image

A Cornerstone in the Supply Chain of Cell-based Therapies

whitePaper | February 15, 2023

The diverse therapeutic attributes of mesenchymal stromal cells (MSCs) lend to their rapid development as cellular therapeutics. These unique attributes include potent immu nomodulatory properties [1,2], the potential to differentiate into multiple cell lineages.

Read More
news image

Leveraging innovations in plasmid manufacturing to bring advanced therapies to market

whitePaper | December 13, 2022

The global demand for plasmid DNA has increased dramatically in recent years, fueled by a surge in the clinical development of next-generation cell and gene therapy products and more recently by the success of COVID-19 vaccines.

Read More
news image

Further Discussion on Plasmids to Establish Release Specifications Using a Risk-Based Approach to Manage Supply

whitePaper | December 6, 2022

BioPhorum’s mission is to create environments where the global biopharmaceutical industry can collaborate and accelerate its rate of progress, for the benefit of all.

Read More
news image

Scalable Rubella production in scale-X™ bioreactor with MRC-5 cells

whitePaper | November 18, 2022

Due to vaccine delivery gap for Rubella disease, global immunization is still limited in some parts of the world. In this paper we will demonstrate how one scale-X™ carbo fixed-bed bioreactor system.

Read More
news image

Bold Goals for U.S. Biotechnology and Biomanufacturing

whitePaper | March 22, 2023

The world is on the cusp of an industrial revolution fueled by biotechnology and biomanufacturing. Emerging biological technologies are and will continue to transform the foundation of our physical world – everything from clothing, to plastics, to fuels, to concrete.

Read More
news image

Optimizing Freeze-Thaw Processes for Cell and Gene Therapy Commercialization

whitePaper | June 23, 2022

Cell and gene therapies require both efficient and reliable freeze-thaw systems. Building the most effective system depends on selecting the right materials and instruments.

Read More

Spotlight

Quintica

Streamlining and automating business processes and workflows, capturing and analyzing key customer data from internal and external sources and the proactive monitoring of infrastructure and support applications with real time visibility all in one location is at the heart of delivering better customer experiences.

Events